Dogwood Therapeutics, Inc.
DWTX
$6.21
-$0.01-0.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.29M | 1.35M | 1.99M | 5.23M | 1.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.81M | 3.92M | 4.43M | 7.54M | 2.30M |
| Operating Income | -15.81M | -3.92M | -4.43M | -7.54M | -2.30M |
| Income Before Tax | -15.75M | -3.81M | -10.73M | -7.73M | -2.28M |
| Income Tax Expenses | -1.40K | 100.00 | 190.50K | -500.00 | -- |
| Earnings from Continuing Operations | -15.74M | -3.81M | -10.93M | -7.73M | -2.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.74M | -3.81M | -10.93M | -7.73M | -2.28M |
| EBIT | -15.81M | -3.92M | -4.43M | -7.54M | -2.30M |
| EBITDA | -15.81M | -3.91M | -4.41M | -7.54M | -- |
| EPS Basic | -8.20 | -1.99 | -8.45 | -6.29 | -2.05 |
| Normalized Basic EPS | -5.13 | -1.25 | -1.99 | -3.69 | -1.28 |
| EPS Diluted | -8.20 | -1.99 | -8.45 | -6.29 | -2.05 |
| Normalized Diluted EPS | -5.13 | -1.25 | -1.99 | -3.69 | -1.28 |
| Average Basic Shares Outstanding | 1.92M | 1.91M | 1.44M | 1.31M | 1.11M |
| Average Diluted Shares Outstanding | 1.92M | 1.91M | 1.44M | 1.31M | 1.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |